{"meshTags":["Humans","Breast","Viscera","Aged","Triple Negative Breast Neoplasms","Female","Middle Aged","Abdominal Neoplasms"],"meshMinor":["Humans","Breast","Viscera","Aged","Triple Negative Breast Neoplasms","Female","Middle Aged","Abdominal Neoplasms"],"genes":["Progesterone receptor","PgR","Human epidermal growth factor receptor 2","HER2"],"organisms":["9606"],"publicationTypes":["Case Reports","English Abstract","Journal Article","Review"],"abstract":"Breast carcinoma is a heterogeneous disease. Clinical treatment of metastases from triple negative-Estrogen receptor-(ER(-), Progesterone receptor (PgR)(-), Human epidermal growth factor receptor 2(HER2)(-)) primary breast cancer and metachronous second cancer in visceral organs is different. In this article we report two cases of visceral metastases from two patients with Stage IV triple negative primary breast cancer. We presented morphology findings and immunophenotype of all lesions and we offered a practical recommendation for diagnosis of similar cases.","title":"[Visceral metastases of triple negative breast cancers with contribution of cases and review of the literature].","pubmedId":"25993741"}